HAEMONETICS CORPORATION Environmental Analytics
Environmental and financial analysis dashboard for HAEMONETICS CORPORATION. Industry: MANUFACTURING
Company Overview for HAEMONETICS CORPORATION
Highlights
Showing data for FY2022
Operational Environmental Cost
$5.57m
Operational Environmental Cost Intensity
0.48%
Total Environmental Cost
N/A
Total Environmental Cost Intensity
N/A
ΔOperational Environmental Cost (2020-2022)
$0.24m
Decoupling Rate (2020-2022)
12%
Adjusted EBITDA
$204m
Adjusted EBITDA Margin
17%
Environmental cost statement
Showing data for FY2022
| USD MM | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| OPERATIONAL SOCIAL COST OF CARBON | ||||
| 5.87% | 22.29% | N/A | ||
| 0.11% | 0.10% | 0.11% | N/A | |
| -0.54% | -0.68% | N/A | ||
| 0.50% | 0.44% | 0.37% | N/A | |
| $5m | $5m | $6m | N/A | |
| 0.64% | 3.77% | N/A | ||
| 0.61% | 0.54% | 0.48% | N/A | |
| INDIRECT SOCIAL COST OF CARBON | ||||
| N/A | N/A | N/A | ||
| N/A | N/A | N/A | N/A | |
| N/A | N/A | N/A | ||
| N/A | N/A | N/A | N/A | |
All figures are denominated in millions of USD. USD is the base currency used to monetize, other currency equivalents are calculated using end of year exchange rates. Scope 2: Social Cost of Carbon is calculated using market-based emissions data. | ||||
Environmental cost bridge
Showing data for FY2022
Integrated financial analysis
Highlights
Showing data for FY2022
Adjusted EBITDA Margin
17%
Adjusted EBIT Margin
7.65%
EV / Adjusted EBITDA
Company Value: Placeholder
Industry Average: Placeholder
Coming soon
EV / Adjusted EBIT
Company Value: Placeholder
Industry Average: Placeholder
Coming soon
Integrated income statement
Showing data for FY2022
| USD MM | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| INCOME STATEMENT | ||||
$870m | $993m | $1,169m | $1,309m | |
| 14.10% | 17.67% | 12.01% | ||
N/A | $795m | $959m | $1,030m | |
| 0.00% | 80.01% | 82.03% | 78.66% | |
N/A | $199m | $210m | $279m | |
| 0.00% | 19.99% | 17.97% | 21.34% | |
N/A | $102m | $95m | $175m | |
| 0.00% | 10.31% | 8.13% | 13.35% | |
| ENVIRONMENTAL COST DATA | ||||
$5m | $5m | $6m | N/A | |
| 0.61% | 0.54% | 0.48% | 0.00% | |
| FINANCIAL DATA ADJUSTED FOR OPERATIONAL ENVIRONMENTAL COST | ||||
N/A | $193m | $204m | N/A | |
| 0.00% | 19.45% | 17.50% | 0.00% | |
N/A | $97m | $89m | N/A | |
| 0.00% | 9.77% | 7.65% | 0.00% | |
All figures are denominated in millions of USD. USD is the base currency used to monetize, other currency equivalents are calculated using end of year exchange rates. | ||||
Environmental EBITDA bridge
Showing data for FY2022
Industry benchmark
MANUFACTURE OF MEDICAL AND DENTAL INSTRUMENTS AND SUPPLIES
Scope 1 (% of Sales)
0.11%
Scope 2 (% of Sales)
0.37%
Operational Environmental Cost Intensity
0.48%
Scope 3 (% of Sales)
N/A
Total Environmental Cost Intensity
N/A
Selected peer group
Showing data for FY2022
NAME | COUNTRY | OPERATIONAL ENV. COST | OPERATIONAL ENV. COST INTENSITY |
|---|---|---|---|
HAEMONETICS CORPORATION | US | $6m | 0.48% |
Loading similar companies data...
Industry distribution
Showing data for FY2022
Note: Outliers are calculated using the 1.5 * IQR method, where values outside Q1 - 1.5 * IQR and Q3 + 1.5 * IQR are considered outliers.
Estimated Social Cost of Carbon Scope 3 breakdown
Percentage breakdown of Social Cost of Carbon Scope 3 into various categories
Showing data for FY2022
SCOPE 3 CATEGORY | Company (USD) | Company % | Industry Avg (USD) | Industry Avg % |
|---|---|---|---|---|
Purchased goods (1 & 2) | N/A | N/A | N/A | N/A |
Energy-related activities (3) | N/A | N/A | N/A | N/A |
Upstream transportation (4) | N/A | N/A | N/A | N/A |
Waste (5) | N/A | N/A | N/A | N/A |
Business travel (6) | N/A | N/A | N/A | N/A |
Commuting (7) | N/A | N/A | N/A | N/A |
Upstream leased assets (8) | N/A | N/A | N/A | N/A |
Downstream transportation (9) | N/A | N/A | N/A | N/A |
Processing of products (10) | N/A | N/A | N/A | N/A |
Use of products (11) | N/A | N/A | N/A | N/A |
Final treatment of products (12) | N/A | N/A | N/A | N/A |
Downstream leased assets (13) | N/A | N/A | N/A | N/A |
Franchises (14) | N/A | N/A | N/A | N/A |
Investments (15) | N/A | N/A | N/A | N/A |
Total | $0m | 100.00% | $0m | 100.00% |
Scope 3 breakdown visualization
Showing data for FY2022